Witjes JA - Search Results

1

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.

Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ; EORTC Genito-Urinary Tract Cancer Collaborative Group. Brausi M, et al. Among authors: witjes ja. Eur Urol. 2002 May;41(5):523-31. doi: 10.1016/s0302-2838(02)00068-4. Eur Urol. 2002. PMID: 12074794

2

Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature.

Witjes JA, Debruyne FM, van der Meijden AP. Witjes JA, et al. Eur Urol. 1991;20(2):170-2. doi: 10.1159/000471691. Eur Urol. 1991. PMID: 1752279 Review.

3

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin.

De Boer EC, De Jong WH, Van Der Meijden AP, Steerenberg PA, Witjes JA, Vegt PD, Debruyne FM, Ruitenberg EJ. De Boer EC, et al. Among authors: witjes ja. Cancer Immunol Immunother. 1991;33(6):411-6. doi: 10.1007/BF01741603. Cancer Immunol Immunother. 1991. PMID: 1878894 Free PMC article.

4

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

5

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: witjes wp, witjes ja. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

6

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: witjes wp, witjes ja. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

7

Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study.

Witjes JA, Fransen MP, van der Meijden AP, Doesburg WH, Debruyne FM. Witjes JA, et al. Urol Int. 1993;51(2):67-72. doi: 10.1159/000282516. Urol Int. 1993. PMID: 8351757 Clinical Trial.

8

Intravesical instillation therapy: alternative treatments.

Debruyne FM, van der Meijden AP, Witjes JA. Debruyne FM, et al. Among authors: witjes ja. Recent Results Cancer Res. 1993;126:119-25. doi: 10.1007/978-3-642-84583-3_11. Recent Results Cancer Res. 1993. PMID: 8456182 Review. No abstract available.

9

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. J Urol. 1993 Jul;150(1):60-4. doi: 10.1016/s0022-5347(17)35397-1. J Urol. 1993. PMID: 8510276

10

Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.

van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: witjes ja. Urology. 1996 Sep;48(3):357-64. doi: 10.1016/S0090-4295(96)00210-5. Urology. 1996. PMID: 8804485 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page